Leerink analyst Daina Graybosch upgraded 2seventy Bio to Outperform from Market Perform with a price target of $18, up from $5.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TSVT:
- 2seventy bio Announces Asset Sale and Leadership Changes
- 2seventy bio Executive Leadership Shuffle and New Appointments
- 2seventy bio Announces Strategic Restructuring and Asset Sale
- 2seventy bio Divests Programs to Regeneron Pharmaceuticals
- 2seventy Bio names Chip Baird CEO, Vicki Eatwell CFO upon transaction closing
